GlassScriptPhysician profile
Sharynn D Hall
NPI 1538276118
$1,230.97
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $892 · 2020: $274 · 2021: $65.03.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $178.95 | 2019-2020 | |
| Janssen Biotech, INC. | $173.55 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $125.16 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $120.45 | 2019-2021 | |
| Genentech USA, INC. | $100.69 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $57.87 | 2019 | |
| Genzyme Corporation | $51.31 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.53 | 2019 | |
| Alexion Pharmaceuticals, INC. | $44.55 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $41.12 | 2019-2020 | |
| Celgene Corporation | $37.34 | 2019-2021 | |
| Puma Biotechnology, INC. | $33.75 | 2019 | |
| Gilead Sciences, INC. | $25.52 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $25.09 | 2019 | |
| Jazz Pharmaceuticals INC. | $23.51 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $22.55 | 2019 | |
| Exelixis INC. | $18.00 | 2019 | |
| Seagen INC. | $16.76 | 2019 | |
| Abbvie INC. | $16.15 | 2019 | |
| Rigel Pharmaceuticals, INC. | $15.60 | 2019 | |
| Tesaro, INC. | $15.37 | 2019 | |
| Merck Sharp & Dohme LLC | $15.26 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.90 | 2019 | |
| Amgen INC. | $10.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharynn Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.